NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Colby Ott, Amber Burns, Edward Sisco, Luis Eduardo Arroyo
Effective and rapid screening methods for seized drug analysis are crucial to ensure the safety of first responders and laboratory personnel, while reducing overall analysis time and improving reliability. The drug landscape has been overwhelmed by
Meghan Appley, Liz Robinson, Allison Thomson, Erin Russell, Edward Sisco
Deaths attributed to drug overdoses are constantly on the rise, but drug trends are frequently changing and often differ across geographical regions. Current analytical techniques are limited in their abilities to rapidly identify drugs that would inform
Controlled substances are one of the most frequently analyzed types of evidence in forensic laboratories. An increase in frequency of seizures in recent years has necessitated a need for rapid screening techniques to decrease case backlogs and expedite
Reductions in instrument size, weight, and power continue to facilitate the development and application of field-deployable devices for investigative purposes. Portable analytical instrumentation supporting the rapid and reliable identification of two
Chuck Barber, Colleen E. Bryan Sallee, Carolyn Burdette, Shaun Kotoski, Melissa M. Phillips, Walter Brent Wilson, Laura Wood
In 2020, NIST launched Cannabis Laboratory Quality Assurance Program (CannaQAP) to improve the comparability of the analytical measurements of cannabis and cannabis-derived products in forensic and cannabis (hemp and marijuana) testing laboratories
Rapid identification of new or emerging psychoactive substances remains a critical challenge in drug chemistry laboratories. Current analytical protocols are well designed for confirmation of known substances yet present struggles when potentially new
Edward Sisco, Meghan Appley, Stephen Tennyson, Arun Moorthy
Chromatographic-less mass spectrometry techniques like direct analysis in real time mass spectrometry (DART-MS) are steadily being employed as seized drug screening tools. However, these newer analytical platforms require new computational methods to best
Edward Sisco, Amber Burns, Elizabeth Schneider, Laurel Bobka, Ikenna Ikpeama
Direct analysis in real time mass spectrometry (DART-MS) is an increasingly employed tool for a wide range of forensic applications including seized drug analysis. A significant body of research surrounds DART-MS for the analysis of seized drugs and how it
Drug scheduling has directed the testing approaches for forensic laboratories since the 1970s when Cannabis (marijuana and hemp) and its psychoactive constituent, Δ9-tetrahydrocannabinol (Δ9-THC), were classified as Schedule 1 controlled substances. Seized
Edward Sisco, Amber Burns, Elizabeth Schneider, Ikenna Ikpeama
Rapid and accurate screening tools for seized drug analysis continue to be needed due to the complexities associated with the emerging drug landscape. Direct analysis in real-time mass spectrometry (DART-MS) is one technique that has been used for this
Edward Sisco, Amber Burns, Elizabeth Schneider, Charles R. Miller, IV, Laurel Bobka
As the challenges faced by drug chemists continue to persist, due the presence of synthetic opioids, novel psychoactive substances, and other emerging drugs, laboratories are continuing to look for new analytical approaches or techniques to ease the
Edward Sisco, Amber Burns, Elizabeth Schneider, Charles R. Miller, IV, Laurel Bobka
As the challenges faced by drug chemists continue to persist, due the presence of synthetic opioids, novel psychoactive substances, and other emerging drugs, laboratories are continuing to look for new analytical approaches or techniques to ease the
Edward Sisco, Amber Burns, Elizabeth Schneider, Charles R. Miller, IV, Laurel Bobka
As the challenges faced by drug chemists continue to persist, due the presence of synthetic opioids, novel psychoactive substances, and other emerging drugs, laboratories are continuing to look for new analytical approaches or techniques to ease the
Edward Sisco, Amber Burns, Elizabeth Schneider, Charles R. Miller, IV, Laurel Bobka
As the challenges faced by drug chemists continue to persist, due the presence of synthetic opioids, novel psychoactive substances, and other emerging drugs, laboratories are continuing to look for new analytical approaches or techniques to ease the
With the increased presence of novel psychoactive substances (NPSs) in casework, seized drug analysis has become more complex and challenging. To assist in addressing these challenges, a suite of targeted gas chromatography mass spectrometry (GC-MS)
With the increased prevalence of novel psychoactive substances (NPSs), seized drug analysis has become more complex and challenging due, in part, to changing chemical structures and isomeric species. To assist in addressing these challenges a series of